International Clinical Trial: A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07525960) titled 'A Study in Adult Males With X-linked Congenital Nephrogenic Diabetes Insipidus to Test the Effects of NDI-5001 Given for Multiple Days and to Test How NDI-5001 is Tolerated and Taken up in the Body' on April 6.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Condition: X-linked Congenital Nephrogenic Diabetes Insipidus

Intervention: Drug: NDI-5001

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment...